Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients (NCT00295139) | Clinical Trial Compass
CompletedNot Applicable
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients
United States293 participantsStarted 2005-01
Plain-language summary
The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment. The researchers will also determine if adding a case management component (Critical Time Intervention; CTI) to the intervention will increase treatment engagement and retention.
Who can participate
Age range18 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* a diagnosis of schizophrenia or schizoaffective disorder or a diagnosis of other severe mental disorder including bipolar disorder, major depression, or severe anxiety disorder (by definition, the patient has worked 25% or less of the past year; and/or the patient receives payment for mental disability)
* a diagnosis of current dependence for opiates, cocaine, or marijuana
* ability and willingness to attend treatment sessions for 6 months
* ability and willingness to provide consent to participate
* enrolled in mental health care
Exclusion Criteria:
* documented history of severe neurological disorder or severe head trauma with loss of consciousness
* severe or profound mental retardation as indicated by chart review
* inability to effectively participate in the baseline assessments due to intoxication or psychiatric symptoms on two successive appointments
* had a substantial trial in either intervention of the Evaluation of Behavioral Treatment for Substance Abuse in Schizophrenia protocol (H-20680)
* inability to attend group sessions due to transportation or other logistical problems
* inability to attend scheduled treatment sessions on a regular basis for any reason, or to appropriately participate in research activities due to behavioral or psychiatric problems
What they're measuring
1
Urinalysis
Timeframe: Baseline, 2 and 4 months, post and 6-month follow-up, and at each treatment session